Lisanti Capital Growth’s Omnicell OMCL Stock Holding History

Lisanti Capital Growth’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-42,155	Closed	-$7.61M	–	138
2021 Q4	$7.61M	Buy	42,155 +10,100	+32%	+$1.75M	1.1%	31
2021 Q3	$4.76M	Buy	32,055 +10,510	+49%	+$1.61M	0.7%	57
2021 Q2	$3.26M	Sell	21,545 -215	-1%	-$29.9K	0.4%	93
2021 Q1	$2.83M	Buy	+21,760	New	+$2.79M	0.36%	104
2020 Q2	–	Sell	-36,090	Closed	-$2.37M	–	138
2020 Q1	$2.37M	Buy	+36,090	New	+$2.88M	0.78%	54
2019 Q3	–	Sell	-38,920	Closed	-$3.35M	–	118
2019 Q2	$3.35M	Sell	38,920 -6,715	-15%	-$546K	1.09%	39
2019 Q1	$3.69M	Buy	45,635 +7,695	+20%	+$576K	1.31%	23
2018 Q4	$2.32M	Buy	+37,940	New	+$2.57M	0.94%	49
2017 Q4	–	Sell	-23,325	Closed	-$1.19M	–	124
2017 Q3	$1.19M	Buy	+23,325	New	+$1.12M	0.75%	60
2016 Q4	–	Sell	-10,630	Closed	-$407K	–	101
2016 Q3	$407K	Sell	10,630 -11,610	-52%	-$433K	0.51%	83
2016 Q2	$761K	Buy	+22,240	New	+$694K	1.15%	36

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Lisanti Capital Growth's OMCL Position: Q1 2022 in Review

Lisanti Capital Growth sold out of Omnicell (OMCL) in Q1 2022, closing a stake of 42,155 shares — an estimated $7.61M sold.

Lisanti Capital Growth first reported a position in OMCL in Q2 2016 and held it in 11 quarters. The position peaked at $7.61M in Q4 2021. 397 funds tracked by Wall St. Rank hold OMCL as of Q1 2022.

Lisanti Capital Growth reported no remaining Omnicell position as of Q1 2022 after selling out during the quarter.
Lisanti Capital Growth sold 42,155 Omnicell shares in Q1 2022, an estimated $7.61M.
Lisanti Capital Growth first reported a position in Omnicell in Q2 2016 and held it in 11 quarters.
Lisanti Capital Growth's Omnicell position peaked at $7.61M in Q4 2021.
397 funds tracked by Wall St. Rank held Omnicell as of Q1 2022.

Based on Lisanti Capital Growth's 13F filing for Q1 2022, filed 12 May 2022.